SCHEMBL2169936

SCHEMBL2169936

CC(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)c(NC3CCN(C)CC3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.49
TRIM24 O15164 1/20 0.49
BRD1 O95696 1/20 0.49
BRPF1 P55201 1/20 0.49
CYP3A4 P08684 3/20 0.48
CYP2D6 P10635 2/20 0.48
DRD2 P14416 4/20 0.46
DRD3 P35462 4/20 0.46
KCNH2 Q12809 1/20 0.46
HTR2A P28223 4/20 0.45
HTR2C P28335 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SLC2A1 P11166 1/20 0.44
PGR P06401 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
UCHL1 P09936 1/20 0.43
USP30 Q70CQ3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2169531 0.89 HTR6 (0.49) HTR6TRIM24BRD1BRPF1CYP3A4
SCHEMBL2183002 0.89 CYP3A4 (0.49) HTR6CYP3A4CYP2D6DRD2DRD3
Hydrochloric Acid SCHEMBL2183767 0.88 HTR6 (0.48) HTR6TRIM24BRD1BRPF1CYP3A4
SCHEMBL2169741 0.88 HSD17B3 (0.49) HTR6CYP3A4CYP2D6DRD2DRD3
SCHEMBL2169945 0.88 HTR6 (0.50) HTR6CYP3A4CYP2D6DRD2DRD3
SCHEMBL2183994 0.88 CYP3A4 (0.49) HTR6TRIM24CYP3A4CYP2D6DRD2
Hydrochloric Acid SCHEMBL6118475 0.87 CYP3A4 (0.48) HTR6TRIM24CYP3A4CYP2D6DRD2
SCHEMBL2170724 0.87 CYP3A4 (0.59) HTR6TRIM24BRD1BRPF1CYP3A4
SCHEMBL6118004 0.84 SLC2A1 (0.53) HTR6TRIM24BRD1BRPF1CYP3A4
SCHEMBL2170099 0.83 CYP3A4 (0.47) HTR6TRIM24BRD1BRPF1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346847-B1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2013-05-15 EP claimed
US-8404720-B2 Aryl sulfonamide amine compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2013-03-26 US claimed
US-20120129816-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2012-05-24 US claimed
EP-2346847-B1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2013-05-15 EP disclosed
US-8404720-B2 Aryl sulfonamide amine compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2013-03-26 US disclosed
US-20120129816-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2012-05-24 US disclosed
EP-2346847-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS Suven Life Sciences Limited (IN) 2011-07-27 EP disclosed
WO-2010032258-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129816-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS HTR6, HTR1A, HTR5A HTR6 1/4885TRIM24 4385/4885BRD1 4085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.